- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07951177
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion. (PED-MR)
Pediatric Eustachian Tube Dilatation in the Management of Mesotympanic Retraction With Effusion: a Multicenter Randomized Study Versus Standard Treatment.
The goal of this clinical investigation is to evaluate the effectiveness of ETD + standard treatment versus standard treatment only, on the improvement of the tympanic membrane retraction, up to 18 months after intervention in children aged ]8-17[ with posterior mesotympanic retraction and middle ear effusion.
연구 개요
상태
연구 유형
등록 (추정된)
단계
- 해당 없음
연락처 및 위치
연구 연락처
- 이름: Fabian BLANC, Dr
- 전화번호: +33 0668248182
- 이메일: fabian-blanc@chu-montpellier.fr
연구 장소
-
-
-
Montpellier, 프랑스, 34000
- Fabian BLANC
-
연락하다:
- Fabian BLANC
- 전화번호: +33 0668248182
- 이메일: fabian-blanc@chu-montpellier.fr
-
-
APHM
-
Marseille, APHM, 프랑스, 13005
- Richard NICOLLAS
-
연락하다:
- Richard NICOLLAS, PhD
- 전화번호: +33 0491386709
- 이메일: richard.nicollas@ap-hm.fr
-
-
APHP Hôpital Necker
-
Paris, APHP Hôpital Necker, 프랑스, 75006
- François SIMON
-
연락하다:
- François SIMON, PhD
- 전화번호: +33 0153104600
- 이메일: f.simon@aphp.fr
-
-
APHP Hôpital Robert Debre
-
Paris, APHP Hôpital Robert Debre, 프랑스, 75019
- Thiery VAN DEN ABBEELE
-
연락하다:
- Thiery VAN DEN ABBEELE, PhD
- 전화번호: +33 0140032179
- 이메일: thierry.van-den-abbeele@aphp.fr
-
부수사관:
- Natacha TEISSIER, PhD
-
부수사관:
- Charlotte BENOIT, Dr
-
부수사관:
- Emilie BOIS, Dr
-
-
HCL Hôptial Femme Mere Enfant
-
Lyon, HCL Hôptial Femme Mere Enfant, 프랑스, 69677
- Sonia AYARI
-
연락하다:
- Sonia AYARI, PhD
- 전화번호: +33 0427855729
- 이메일: sonia.ayari-khalfallah@chu-lyon.fr
-
부수사관:
- Aurélie COUDERT, Dr
-
부수사관:
- Maxime TABEY, Dr
-
-
Hôpital Purpan
-
Toulouse, Hôpital Purpan, 프랑스, 40031
- Marie-Noël CALMELS
-
연락하다:
- Marie-Noël CALMES, PhD
- 전화번호: +33 0561779009
- 이메일: calmels.mn@chu-toulouse.fr
-
부수사관:
- Blandine BALADI
-
부수사관:
- Yohan GALLOIS
-
-
Hôpital Salengro
-
Lille, Hôpital Salengro, 프랑스, 5900
- Philippine TOULEMONDE
-
연락하다:
- Philippine TOULEMONDE, Dr
- 전화번호: +33 0320446205
- 이메일: philippine.toulemonde@chu-lille.fr
-
부수사관:
- Hugo DELERRY
-
부수사관:
- Christophe VINCENT
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Children aged strictly between 8 and 17 years of age
- Presenting a posterior mesotympanic retraction (grade II or III without adherence to the promontory from Sade's grade) with effusion
Exclusion Criteria:
- Weight strictly less than 20kg
- Down syndrome
- Craniosynostosis and other head and neck malformations
- History of skull base surgery
- History of skull fracture
- Failure to obtain consent
- Non-affiliation to a social security scheme
- Persons placed under legal protection
- Person participating in another research including a period of exclusion still in progress
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: Eustachian tube dilation added to standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present. ETD involves using a transnasal balloon catheter, during general anesthesia, by the surgeon in charge of the patient. The device will be an Acclarent Aera 6x16 mm balloon, with a pressure set at 12 atm for 2 minutes in the eustachian tube. The manufacturer of the ETD device will organize a training session with hands-on on simulator, for all the principal investigators prior to the start of the study, to ensure homogenous intervention. |
Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical, coupled with the Acclarent Aera™ Eustachian Tube Balloon Dilation System. |
|
활성 비교기: Standard treatment
Standard treatment involves the placement of a tympanostomy tube and adenoidectomy if a hypertrophy of the adenoids is present, during general anesthesia, by the surgeon in charge of the patient. Tube placement will be in the anterior or inferior part of the tympanic membrane. Different design and brand of tympanostomy tube exist and are used in the different centers, leading to putative slightly different outcomes in term of adverse events related to the tympanostomy tube and duration. To decrease the cohort's heterogeneity, we propose to utilize the same tympanostomy tube for all the patients included in the study (Shepard's tympanostomy tube). |
Medical device: Shepard tympanostomy tube, reference PRO 000 310P, manufactured by Pouret Medical. |
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Tympanic membrane retraction
기간: Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
The assessment of tympanic membrane retraction is treated as a survival variable. Tympanic membrane retraction will be blindly assessed by an adjudication committee, through recorded otoendoscopy, based on the Sade's classification (in grade 0, I, II, III, IV, or V). The delay will be calculated as the time from intervention to improvement in tympanic membrane retraction (event), to loss of follow up (censoring), or to the study endpoint (censoring). |
Tympanic membrane retraction will be assessed 3 times during the follow up: at 6, 12 and 18 months.
|
2차 결과 측정
결과 측정 |
측정값 설명 |
기간 |
|---|---|---|
|
Mesotympanic retractation
기간: 6, 12 and 18 months
|
Mesotympanic retractation according to Sade's classification |
6, 12 and 18 months
|
|
Audiometry thresholds
기간: 6, 12 and 18 months
|
Mean of the air-bone gap at 500 Hz, 1000 Hz, 2000 Hz and 4000 Hz |
6, 12 and 18 months
|
|
Tympanometry profile
기간: 6, 12 and 18 months
|
Tympanometry profile (A, B or C) |
6, 12 and 18 months
|
|
The quality of life
기간: 6, 12 and 18 months
|
Quality of Life measured through the OM-6 questionnaires |
6, 12 and 18 months
|
|
The quality of life
기간: 6, 12 and 18 months
|
Quality of Life measured through the PedsQL™ 4.0 questionnaires |
6, 12 and 18 months
|
|
Adverse events in both arms
기간: during the first week
|
Occurrence of adverse events and serious events during the first week, coded according to MedDRA. |
during the first week
|
공동 작업자 및 조사자
수사관
- 수석 연구원: Fabian BLANC, Dr, University Hospital, Montpellier
연구 기록 날짜
연구 주요 날짜
연구 시작 (추정된)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .